any mistakes during cell replication are faulty. The study can't tell us if dostarlimab will work in patients with other types of rectal cancer.Hanna K. Sanoff, an oncologist at the Lineberger Comprehensive Cancer Center at the University of North Carolina,Sanoff cautioned that the outcome was an imperfect proxy for long-term cancer control."Cancer regrowth occurs in 20 to 30% of such patients when the cancer is managed nonoperatively", she said.
Sanoff added that it was unclear if it would be safe to roll out the drug on a large scale because it required specific imaging techniques, such as PET scans, that aren't readily available, and could mean possible tumor regrowth is missed.Possible side effects of this drug include immune-mediate reactions in any organ such as inflammation of the lung inflammation. The in patients that have taken the drug for endometriosis include: fatigue, nausea, diarrhea, anemia, and constipation.
"These results are cause for great optimism, but such an approach cannot yet supplant our current curative treatment approach," Sanoff said.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Early diagnosis of ADHD can nip drug dependency in the bud: studyThe disorder is highly prevalent among patients seeking treatment for drug abuse, researchers say
Source: SundayTimesZA - 🏆 47. / 51 Read more »
AstraZeneca-Daiichi drug shown to cut death rate of women with advanced breast cancerEnhertu extends survival rate of patients compared to standard chemotherapy, data shows
Source: BDliveSA - 🏆 12. / 63 Read more »
Source: dailymaverick - 🏆 3. / 84 Read more »
Source: BISouthAfrica - 🏆 34. / 51 Read more »